{"id":"https://openalex.org/W7201864151","doi":"https://doi.org/10.1177/10445463261477342","title":"Amantadine-Responsive, Benzodiazepine-Resistant Catatonia in an Adolescent With Autism Spectrum Disorder","display_name":"Amantadine-Responsive, Benzodiazepine-Resistant Catatonia in an Adolescent With Autism Spectrum Disorder","alternate_titles":[],"publication_year":2026,"publication_date":"2026-08-07","ids":{"openalex":"https://openalex.org/W7201864151","doi":"https://doi.org/10.1177/10445463261477342","pmid":"https://pubmed.ncbi.nlm.nih.gov/42565358"},"language":"en","primary_location":{"id":"doi:10.1177/10445463261477342","doi":"https://doi.org/10.1177/10445463261477342","is_oa":false,"landing_page_url":"https://doi.org/10.1177/10445463261477342","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7201864151"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007308066","display_name":"E. Lled\u00f3","orcid":"https://orcid.org/0009-0004-8127-8713","observed_orcids":["https://orcid.org/0009-0004-8127-8713"]},"institutions":[{"id":"https://openalex.org/I904013037","display_name":"Universidad Europea de Madrid","ror":"https://ror.org/04dp46240","country_code":"ES","type":"education","lineage":["https://openalex.org/I904013037"]},{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"Enric Lledo-Graell","raw_affiliation_strings":["Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA","Universidad Europea de Madrid, Madrid, Spain"],"raw_orcid":"https://orcid.org/0009-0004-8127-8713","affiliations":[{"raw_affiliation_string":"Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA","institution_ids":["https://openalex.org/I919571938"]},{"raw_affiliation_string":"Universidad Europea de Madrid, Madrid, Spain","institution_ids":["https://openalex.org/I904013037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038011848","display_name":"Pooja Chaudhary","orcid":"https://orcid.org/0000-0003-1586-1703","observed_orcids":["https://orcid.org/0000-0003-1586-1703"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pooja Chaudhary","raw_affiliation_strings":["Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006006878","display_name":"Aivien Do","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aivien Do","raw_affiliation_strings":["Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013424546","display_name":"Kira Elise Gomez","orcid":"https://orcid.org/0000-0003-1194-2354","observed_orcids":["https://orcid.org/0000-0003-1194-2354"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kira Gomez","raw_affiliation_strings":["Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA"],"raw_orcid":"https://orcid.org/0000-0003-1194-2354","affiliations":[{"raw_affiliation_string":"Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039082531","display_name":"Sandy Juste","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandy Juste","raw_affiliation_strings":["Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5145990655","display_name":"Mary Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Evans","raw_affiliation_strings":["Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5146059894","display_name":"Toju James Okotie-Eboh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Toju James Okotie-Eboh","raw_affiliation_strings":["Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025484183","display_name":"Micah Knobles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Micah Knobles","raw_affiliation_strings":["Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053477956","display_name":"C\u00e9sar A. Soutullo","orcid":"https://orcid.org/0000-0003-4348-0772","observed_orcids":["https://orcid.org/0000-0003-4348-0772"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cesar A. Soutullo","raw_affiliation_strings":["Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, The University of Texas (UT) Health\u2014Houston, Houston, Texas, USA","institution_ids":["https://openalex.org/I919571938"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5053477956"],"corresponding_institution_ids":["https://openalex.org/I919571938"],"apc_list":null,"apc_paid":null,"fwci":2.7205,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.82232614,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":"10445463261477342","last_page":"10445463261477342"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13966","display_name":"Neurological and metabolic disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/catatonia","display_name":"catatonia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/autism-spectrum-disorder","display_name":"autism spectrum disorder","score":0.996999979019165},{"id":"https://openalex.org/keywords/amantadine","display_name":"amantadine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/benzodiazepine-resistance","display_name":"benzodiazepine resistance","score":0.9670000076293945},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.8790000081062317},{"id":"https://openalex.org/keywords/electroconvulsive-therapy","display_name":"electroconvulsive therapy","score":0.746999979019165},{"id":"https://openalex.org/keywords/excitation-inhibition-balance","display_name":"excitation-inhibition balance","score":0.7910000085830688},{"id":"https://openalex.org/keywords/dopaminergic-modulation","display_name":"dopaminergic modulation","score":0.8790000081062317},{"id":"https://openalex.org/keywords/adolescents","display_name":"adolescents","score":0.4090000092983246},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C2778941822","wikidata":"https://www.wikidata.org/wiki/Q501571","display_name":"Catatonia","level":3,"score":0.9513999819755554},{"id":"https://openalex.org/C2779706987","wikidata":"https://www.wikidata.org/wiki/Q408265","display_name":"Lorazepam","level":2,"score":0.7749999761581421},{"id":"https://openalex.org/C2777374534","wikidata":"https://www.wikidata.org/wiki/Q409761","display_name":"Amantadine","level":2,"score":0.621399998664856},{"id":"https://openalex.org/C164953862","wikidata":"https://www.wikidata.org/wiki/Q7256440","display_name":"Psychomotor learning","level":3,"score":0.5529000163078308},{"id":"https://openalex.org/C2778538070","wikidata":"https://www.wikidata.org/wiki/Q1436063","display_name":"Autism spectrum disorder","level":3,"score":0.5227000117301941},{"id":"https://openalex.org/C205778803","wikidata":"https://www.wikidata.org/wiki/Q38404","display_name":"Autism","level":2,"score":0.4781999886035919},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4715999960899353},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47119998931884766},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4691999852657318},{"id":"https://openalex.org/C2776202747","wikidata":"https://www.wikidata.org/wiki/Q3064951","display_name":"Psychomotor retardation","level":3,"score":0.42289999127388},{"id":"https://openalex.org/C3018162438","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Adjunctive treatment","level":2,"score":0.41940000653266907},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.38530001044273376},{"id":"https://openalex.org/C2777330709","wikidata":"https://www.wikidata.org/wiki/Q131543","display_name":"Electroconvulsive therapy","level":3,"score":0.3758000135421753},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.3314000070095062},{"id":"https://openalex.org/C2780325297","wikidata":"https://www.wikidata.org/wiki/Q834047","display_name":"Schizoaffective disorder","level":3,"score":0.32899999618530273},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.32330000400543213},{"id":"https://openalex.org/C2779753318","wikidata":"https://www.wikidata.org/wiki/Q160796","display_name":"Delirium","level":2,"score":0.3138999938964844},{"id":"https://openalex.org/C2776153860","wikidata":"https://www.wikidata.org/wiki/Q394129","display_name":"Psychomotor agitation","level":2,"score":0.30820000171661377},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.3068000078201294},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.2976999878883362},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.29499998688697815},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.29109999537467957},{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.28769999742507935},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.28459998965263367},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.26739999651908875},{"id":"https://openalex.org/C2778460930","wikidata":"https://www.wikidata.org/wiki/Q7447053","display_name":"Seizure threshold","level":4,"score":0.2644999921321869},{"id":"https://openalex.org/C2908980008","wikidata":"https://www.wikidata.org/wiki/Q7256438","display_name":"Psychomotor disorder","level":4,"score":0.25600001215934753},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.2542000114917755},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.2522999942302704},{"id":"https://openalex.org/C2779388368","wikidata":"https://www.wikidata.org/wiki/Q3450985","display_name":"Neurodevelopmental disorder","level":3,"score":0.2502000033855438}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1177/10445463261477342","doi":"https://doi.org/10.1177/10445463261477342","is_oa":false,"landing_page_url":"https://doi.org/10.1177/10445463261477342","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:42565358","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42565358","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1994400229","https://openalex.org/W2014310417","https://openalex.org/W2016062742","https://openalex.org/W2054379390","https://openalex.org/W2064531284","https://openalex.org/W2141199859","https://openalex.org/W2142050212","https://openalex.org/W2143751311","https://openalex.org/W2153801198","https://openalex.org/W2155207255","https://openalex.org/W2207665868","https://openalex.org/W2471657101","https://openalex.org/W2536129703","https://openalex.org/W2790263068","https://openalex.org/W2885226061","https://openalex.org/W2902870485","https://openalex.org/W2921360746","https://openalex.org/W2950509008","https://openalex.org/W2965661162","https://openalex.org/W2975599668","https://openalex.org/W3159760252","https://openalex.org/W4212886652","https://openalex.org/W4247665917","https://openalex.org/W4281992813","https://openalex.org/W4317103525","https://openalex.org/W4364354368","https://openalex.org/W4378471468","https://openalex.org/W4381433696","https://openalex.org/W4382199983","https://openalex.org/W4400438829","https://openalex.org/W4400786596","https://openalex.org/W4401446286","https://openalex.org/W4403334448","https://openalex.org/W7139955820"],"related_works":["https://openalex.org/W2967075965","https://openalex.org/W7166686225","https://openalex.org/W4412492538","https://openalex.org/W3204970786","https://openalex.org/W2910254105","https://openalex.org/W4387493747","https://openalex.org/W1994400229","https://openalex.org/W2399178613","https://openalex.org/W2888938433","https://openalex.org/W2086296425"],"abstract_inverted_index":{"BACKGROUND:":[0],"Catatonia":[1,172],"is":[2,24,241,248,252],"a":[3,76,228],"severe":[4],"neuropsychiatric":[5],"syndrome":[6],"increasingly":[7],"recognized":[8],"in":[9,175,189,203,235],"autism":[10],"spectrum":[11],"disorder":[12],"(ASD),":[13],"where":[14],"symptom":[15],"overlap":[16,202],"can":[17],"delay":[18],"diagnosis.":[19],"In":[20,185],"pediatric":[21],"populations,":[22],"it":[23],"associated":[25],"with":[26,79,88,237],"significant":[27],"morbidity":[28],"and":[29,34,94,105,111,137,158,168,179,192,205,221,246],"requires":[30],"prompt":[31],"intervention.":[32],"Benzodiazepines":[33],"electroconvulsive":[35],"therapy":[36],"(ECT)":[37],"are":[38],"first-line":[39],"treatments;":[40],"however,":[41],"access":[42,131],"to":[43,49,128,132,139,209],"ECT":[44,247],"may":[45,198,212,226],"be":[46,227],"limited":[47],"due":[48],"legal":[50],"or":[51,243],"institutional":[52],"constraints.":[53],"Alternative":[54],"pharmacological":[55],"strategies,":[56],"including":[57,151],"N-methyl-D-aspartate":[58],"(NMDA)":[59],"receptor":[60,219],"antagonists":[61],"such":[62],"as":[63],"amantadine,":[64],"have":[65,194],"been":[66,195],"proposed,":[67],"although":[68],"evidence":[69],"remains":[70],"limited.":[71],"CASE":[72],"PRESENTATION:":[73],"We":[74],"report":[75],"15-year-old":[77],"male":[78],"ASD":[80,238],"who":[81],"developed":[82],"progressive":[83],"catatonia":[84,234],"over":[85],"1":[86],"year,":[87],"psychomotor":[89,156],"slowing,":[90],"speech":[91,153],"latency,":[92],"staring,":[93],"functional":[95],"decline":[96],"requiring":[97],"hospitalization.":[98],"Symptoms":[99],"emerged":[100],"after":[101,108],"using":[102],"over-the-counter":[103],"supplements":[104],"partially":[106],"improved":[107,155],"discontinuation.":[109],"Medical":[110],"neurological":[112],"workup":[113],"was":[114,135,163],"unremarkable.":[115],"A":[116],"lorazepam":[117,240],"challenge":[118],"produced":[119],"partial":[120],"improvement,":[121,150],"but":[122],"high-dose":[123],"benzodiazepines":[124],"were":[125],"insufficient.":[126],"Due":[127],"lack":[129],"of":[130],"ECT,":[133],"amantadine":[134],"initiated":[136],"titrated":[138],"200":[140],"mg":[141],"twice":[142],"daily.":[143],"Within":[144],"days,":[145],"the":[146,201,206],"patient":[147],"showed":[148],"marked":[149],"increased":[152],"output,":[154],"activity,":[157],"enhanced":[159],"social":[160],"engagement.":[161],"Improvement":[162],"supported":[164],"by":[165],"clinical":[166],"observations":[167],"caregiver":[169],"reports.":[170],"DISCUSSION:":[171],"involves":[173],"dysfunction":[174],"dopaminergic":[176],"(DA),":[177],"GABAergic,":[178],"glutamatergic":[180],"systems":[181],"within":[182],"cortico-striato-thalamo-cortical":[183],"circuits.":[184],"ASD,":[186],"similar":[187],"abnormalities":[188],"excitatory-inhibitory":[190],"balance":[191],"connectivity":[193],"reported,":[196],"which":[197],"partly":[199],"explain":[200],"presentation":[204],"potential":[207],"vulnerability":[208],"catatonia.":[210],"Amantadine":[211,225],"help":[213],"restore":[214],"this":[215],"imbalance":[216],"through":[217],"NMDA":[218],"antagonism":[220],"DA":[222],"modulation.":[223],"CONCLUSION:":[224],"viable":[229],"adjunctive":[230],"treatment":[231],"for":[232],"benzodiazepine-insufficient":[233],"adolescents":[236],"when":[239],"insufficient":[242],"poorly":[244],"tolerated":[245],"unavailable.":[249],"Further":[250],"research":[251],"needed.":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7201864151","counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T13:44:29.811591","created_date":"2026-08-08T00:00:00"}
